142 related articles for article (PubMed ID: 23677568)
1. The co-expression of ERβ2 and IL-12Rβ2 is better prognostic factor in non-small-cell lung cancer progression.
Liu ZG; Lei YY; Li WW; Chen ZG
Med Oncol; 2013; 30(3):592. PubMed ID: 23677568
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptorβ2 regulates interlukin-12 receptorβ2 expression via p38 mitogen-activated protein kinase signaling and inhibits non-small-cell lung cancer proliferation and invasion.
Liu ZG; Jiao XY; Chen ZG; Feng K; Luo HH
Mol Med Rep; 2015 Jul; 12(1):248-54. PubMed ID: 25695486
[TBL] [Abstract][Full Text] [Related]
3. The expression of estrogen receptors β2, 5 identifies and is associated with prognosis in non-small cell lung cancer.
Liu Z; Liao Y; Tang H; Chen G
Endocrine; 2013 Oct; 44(2):517-24. PubMed ID: 23475473
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA_0001946 is insufficiently expressed in tumor tissues, while its higher expression correlates with less lymph node metastasis, lower TNM stage, and improved prognosis in NSCLC patients.
Zhang M; Wen F; Zhao K
J Clin Lab Anal; 2021 Aug; 35(8):e23625. PubMed ID: 34216509
[TBL] [Abstract][Full Text] [Related]
5. The close association between IL‑12Rβ2 and p38MAPK, and higher expression in the early stages of NSCLC, indicates a good prognosis for survival.
Liu Z; Yang W; Yang S; Cai K
Mol Med Rep; 2018 Aug; 18(2):2307-2313. PubMed ID: 29956791
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer.
Chen SW; Wang TB; Tian YH; Zheng YG
Int J Clin Exp Pathol; 2015; 8(11):14983-8. PubMed ID: 26823832
[TBL] [Abstract][Full Text] [Related]
7. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
Yang H; Gao XY; Li P; Jiang TS
Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
[TBL] [Abstract][Full Text] [Related]
8. The expression of ERβ2, Bcl-xl and Bax in non-small cell lung cancer and associated with prognosis.
Liu J; Nie Z; Lei Y; Yang S; Liu Z
Int J Clin Exp Pathol; 2017; 10(9):10040-10046. PubMed ID: 31966894
[TBL] [Abstract][Full Text] [Related]
9. Including positive lymph node count in the AJCC N staging may be a better predictor of the prognosis of NSCLC patients, especially stage III patients: a large population-based study.
Fan Y; Du Y; Sun W; Wang H
Int J Clin Oncol; 2019 Nov; 24(11):1359-1366. PubMed ID: 31183778
[TBL] [Abstract][Full Text] [Related]
10. A hypothesized TNM staging system based on the number and location of positive lymph nodes may better reflect the prognosis for patients with NSCLC.
Shang X; Liu J; Li Z; Lin J; Wang H
BMC Cancer; 2019 Jun; 19(1):591. PubMed ID: 31208403
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA ROR is a novel prognosis factor associated with non-small-cell lung cancer progression.
Qu CH; Sun QY; Zhang FM; Jia YM
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4087-4091. PubMed ID: 29028092
[TBL] [Abstract][Full Text] [Related]
12. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
[TBL] [Abstract][Full Text] [Related]
13. Combined Effect of IL-12Rβ2 and IL-23R Expression on Prognosis of Patients with Laryngeal Cancer.
Tao Y; Tao T; Gross N; Peng X; Li Y; Huang Z; Liu L; Li G; Chen X; Yang J
Cell Physiol Biochem; 2018; 50(3):1041-1054. PubMed ID: 30355949
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of interleukin-8 receptor 2 (IL-8R2) indicates better prognosis in esophageal adenocarcinoma and squamous cell carcinoma procession.
Liang B; Zhao H; Che JB; Wang HJ; Shi GN
Med Oncol; 2014 Aug; 31(8):89. PubMed ID: 24972913
[TBL] [Abstract][Full Text] [Related]
15. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS
Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781
[TBL] [Abstract][Full Text] [Related]
16. A high ratio of IL-12Rβ2-positive tumor-infiltrating lymphocytes indicates favorable prognosis in laryngeal cancer.
Tao Y; Gross N; Liu Y; Zhang L; Li G; Huang Z; Yang J
Oral Oncol; 2017 Nov; 74():148-156. PubMed ID: 29103744
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
[TBL] [Abstract][Full Text] [Related]
18. CHCHD2 is a potential prognostic factor for NSCLC and is associated with HIF-1a expression.
Yin X; Xia J; Sun Y; Zhang Z
BMC Pulm Med; 2020 Feb; 20(1):40. PubMed ID: 32054470
[TBL] [Abstract][Full Text] [Related]
19. Correlation of EGFR Del 19 with Fn14/JAK/STAT signaling molecules in non-small cell lung cancer.
Sun Y; Han Y; Wang X; Wang W; Wang X; Wen M; Xia J; Xing H; Li X; Zhang Z
Oncol Rep; 2016 Aug; 36(2):1030-40. PubMed ID: 27350337
[TBL] [Abstract][Full Text] [Related]
20. Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer.
Liu J; Ping W; Zu Y; Sun W
Int J Clin Exp Pathol; 2014; 7(9):6040-7. PubMed ID: 25337249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]